Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers

NCT02215018 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 44370 TA solution
DRUG: BI 44370 TA tablet
DRUG: Placebo solution
DRUG: Placebo tablet

Sponsor

Boehringer Ingelheim